Huahine – Polynesia

Professionals

The geography of trophoblastic diseases

Low incidence

High incidence

The history of trophoblastic diseases

Year Description Authors
2017Pembrolizumab (immunotherapy)Ghorani
2013Induction PE (ultra-high risk disease)Alifrangis
2006NLRP7 MutationMurdoch
2002WHO/FIGO Score StagingWHO / FIGO
2001WHO diagnostic criteria for GTNWHO
1992FIGO StadiumFIGO
1986EMACO Polychemotherapy Newlands
1983International prognostic factorsWHO
1983Tumeur trophoblastique épithélioïde (ETT)Okabe
1978Tumeur trophoblastique du site placentaire (PSTT)Kurman
1978Androgenetic origin of complete moles Kaji, Ohama
1976Radioimmunoassay βhCGBraunstein
1976English prognostic factorsBagshawe, Charing Cross, London
1974ISSTD FoundationISSTD
1973American prognostic factorsHammond, NCI USA
1968Radioimmunoassay hCG/LHThomas
1962Dactinomycin (for Methotrexate-resistant patients)Ross
1956Choriocarcinoma treated with MethotrexateHertz, Li
1950Immunoassay hCG/LH Delfs, Hon
1950Regression of hCG levels with Methotrexate (hepatoma)Li
1947GTN Grading SystemHertig
1930Gonadotropin bioassays Asheim, Zondek
1928hCG urine (pregnancy and GTD)Zondek
1920Link between GTDs and the placenta Hirose
1894Trophoblast transplanted into the lungSchmorl
1877Choriocarcinoma Chiari
1840Chorioadenoma destruens (malignant disease)Wilton
1761Hydatiform moleHunter
1276Deaths due to hemorrhage (365 children/vesicles delivered)Countess Margareta of Henneberg
500HydatidAetius of Amide
-400Uterine hydropsHippocrates of Kos

Modified on 12/23/2023